Ganaxolone IV for Treatment in Epilepsy
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 2
Sponsors and Collaborators
Marinus Pharmaceuticals, Epilepsy Foundation (EF)
Mechanism of Action
GABA
Mechanism Description
synthetic analog of endogenous allopregnanolone which modulats GABAa Receptors
Populations Tested In
Status Epilepticus
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - 2005 investment
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link